07/01/2025
3:32 PM | Eliem Therapeutics (Issuer)
Climb Bio, Inc. (Issuer)
Thomas Stephen Basil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
3:15 PM | Eliem Therapeutics (Issuer)
Climb Bio, Inc. (Issuer)
Wilson Perrin Megan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/20/2025
3:15 PM | Eliem Therapeutics (Issuer)
Climb Bio, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/20/2025
3:20 PM | Eliem Therapeutics (Issuer)
Climb Bio, Inc. (Issuer)
Pimblett Emily (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2025
3:20 PM | Eliem Therapeutics (Issuer)
Climb Bio, Inc. (Issuer)
Driscoll Cindy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
6:08 AM | Eliem Therapeutics (Filer)
Climb Bio, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2025
3:21 PM | Eliem Therapeutics (Issuer)
Climb Bio, Inc. (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
3:32 PM | Eliem Therapeutics (Filer)
Climb Bio, Inc. (Filer)
| Form DEFA14A | |
05/14/2025
6:05 AM | Eliem Therapeutics (Filer)
Climb Bio, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2025
6:10 AM | Eliem Therapeutics (Filer)
Climb Bio, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/01/2025
6:14 AM | Eliem Therapeutics (Filer)
Climb Bio, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for ELYM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Eliem Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
03/25/2025
3:46 PM | Eliem Therapeutics (Filer)
Climb Bio, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2025
3:35 PM | Eliem Therapeutics (Filer)
Climb Bio, Inc. (Filer)
| Form 424B5 | |
03/20/2025
4:21 PM | Eliem Therapeutics (Issuer)
Climb Bio, Inc. (Issuer)
Pimblett Emily (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
2:56 PM | BML Investment Partners, L.P. (Filed by)
Eliem Therapeutics (Subject)
Climb Bio, Inc. (Subject)
| Form SCHEDULE 13G/A | |
01/15/2025
3:15 PM | Eliem Therapeutics (Issuer)
Climb Bio, Inc. (Issuer)
Kaplan Brett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
3:15 PM | Eliem Therapeutics (Issuer)
Climb Bio, Inc. (Issuer)
Pimblett Emily (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
3:15 PM | Brennan Aoife (Reporting)
Eliem Therapeutics (Issuer)
Climb Bio, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
7:08 AM | Eliem Therapeutics (Filer)
Climb Bio, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
3:15 PM | Eliem Therapeutics (Issuer)
Climb Bio, Inc. (Issuer)
Pimblett Emily (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/24/2024
11:15 PM | Eliem Therapeutics (Filer)
Climb Bio, Inc. (Filer)
| Form EFFECT | |
11/14/2024
8:29 AM | Eliem Therapeutics (Subject)
Climb Bio, Inc. (Subject)
Deep Track Capital, LP (Filed by)
| Form SC 13G/A | |
11/12/2024
3:51 PM | Eliem Therapeutics (Filer)
Climb Bio, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/15/2024
6:08 AM | Eliem Therapeutics (Filer)
Climb Bio, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
8:53 PM | Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
Pimblett Emily (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
4:21 PM | Eliem Therapeutics (Filer)
Eliem Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2024
4:47 PM | Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
Kaplan Brett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
4:40 PM | Eliem Therapeutics (Issuer)
Eliem Therapeutics, Inc. (Issuer)
Kaplan Brett (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/26/2024
6:07 AM | Eliem Therapeutics (Filer)
Eliem Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2024
3:23 PM | AI ETI LLC (Filed by)
Eliem Therapeutics (Subject)
Eliem Therapeutics, Inc. (Subject)
| Form SC 13D/A | |
08/14/2024
5:06 AM | Eliem Therapeutics (Filer)
Eliem Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
5:10 AM | Eliem Therapeutics (Filer)
Eliem Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
